aspirin and cicaprost

aspirin has been researched along with cicaprost in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (71.43)18.2507
2000's2 (28.57)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Breddin, HK; Giedrojc, J1
Breddin, HK; Fellier, H; Giedrojc, J1
Mahler, M; Seifert, W; Spiegel, B; Staks, T1
Birrell, GJ; Grubb, BD; Iggo, A; McQueen, DS1
Fredrich, M; Morser, J; Witt, W; Wydro, R; Zierz, R1
Mitchell, JA; Pepper, JR; Stanford, SJ1

Trials

1 trial(s) available for aspirin and cicaprost

ArticleYear
Synergic effect of cicaprost-clathrate and low-dose acetylsalicylic acid on platelet aggregation in man.
    International journal of clinical pharmacology, therapy, and toxicology, 1992, Volume: 30, Issue:11

    Topics: Adenosine Diphosphate; Adult; Aspirin; Collagen; Drug Combinations; Drug Synergism; Epoprostenol; Humans; Platelet Aggregation; Single-Blind Method

1992

Other Studies

6 other study(ies) available for aspirin and cicaprost

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Effects of combinations of a prostacyclin analogue (Cicaprost) with different antithrombotic agents in a rat microcirculatory thrombosis model.
    International journal of microcirculation, clinical and experimental, 1992, Volume: 11, Issue:3

    Topics: Animals; Aspirin; Drug Synergism; Drug Therapy, Combination; Epoprostenol; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Lysine; Male; Molsidomine; Rats; Rats, Inbred Strains; Thrombosis

1992
Individual and combined effects of a thromboxane receptor antagonist and different antithrombotic agents in a rat microcirculatory thrombosis model.
    Haemostasis, 1992, Volume: 22, Issue:6

    Topics: Animals; Aspirin; Drug Synergism; Epoprostenol; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Lasers; Lysine; Male; Microcirculation; Molsidomine; Rats; Rats, Wistar; Receptors, Thromboxane; Sulfonamides; Thiophenes; Thrombophlebitis; Venules

1992
Effects of paracetamol and aspirin on neural activity of joint mechanonociceptors in adjuvant arthritis.
    British journal of pharmacology, 1991, Volume: 104, Issue:1

    Topics: Acetaminophen; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Aspirin; Epoprostenol; Lysine; Male; Mechanoreceptors; Neural Conduction; Neurons; Nociceptors; Pain; Rats; Rats, Inbred Strains; Salicylates; Sensory Thresholds; Tarsus, Animal

1991
A new animal model of venous thrombosis in rats with low flow conditions in the venous blood stream.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1994, Volume: 5, Issue:2

    Topics: Animals; Anticoagulants; Aspirin; Blood Flow Velocity; Constriction; Disease Models, Animal; Epoprostenol; Heparin; Male; Platelet Aggregation Inhibitors; Prostaglandins, Synthetic; Rats; Rats, Wistar; Recombinant Proteins; Thrombomodulin; Thrombophlebitis; Thromboplastin; Vena Cava, Inferior

1994
Cyclooxygenase-2 regulates granulocyte-macrophage colony-stimulating factor, but not interleukin-8, production by human vascular cells: role of cAMP.
    Arteriosclerosis, thrombosis, and vascular biology, 2000, Volume: 20, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Arteriosclerosis; Aspirin; Bucladesine; Cells, Cultured; Cyclic AMP; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Epoprostenol; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Indans; Indomethacin; Interleukin-1; Interleukin-8; Isoenzymes; Mammary Arteries; Meloxicam; Membrane Proteins; Muscle, Smooth, Vascular; Neutrophils; Prostaglandin-Endoperoxide Synthases; Saphenous Vein; Sulfonamides; Thiazines; Thiazoles; Tumor Necrosis Factor-alpha

2000